Esomeprazole but not pantoprazole is associated with lower plasma concentrations of clopidogrel's active metabolite

Annals of Pharmacotherapy

Volumn 45, Issue 4, 2011, Pages 542-543

  Harmsze, Ankie M ^a,b   van Werkum, Jochem W ^a   Taubert, Dirk ^c   Hackeng, Christian M ^a   Deneer, Vera HM ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; ESOMEPRAZOLE; PANTOPRAZOLE;

CLINICAL ARTICLE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG METABOLISM; HUMAN; LETTER; LOADING DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PLATELET AGGREGATION INHIBITORS; PROTON PUMP INHIBITORS; TICLOPIDINE;

EID: 79955564456     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P425     Document Type: Letter

References (7)

1. Angiolillo DJ, Gibson CM, Cheng S, et al. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther 2011;89:65-74.
2. US Food and Drug Administration safety alert for human medicinal products clopidogrel (marketed as Plavix) and omeprazole (marketed as Prilosec)-drug interaction. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm190848.htm (accessed 2010 Jan 16).
3. Taubert D, Kastrati A, Harlfinger S, et al. Pharmacokinetics of clopidogrel after administration of a high loading dose. Thromb Haemost 2004; 92:311-6.
4. Bhatt DL, Cryer BL, Contant CF, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010;363:1909-17.
5. Hulot JS, Collet JP, Silvain J, et al. Cardiovascular risk in clopidogreltreated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis. J Am Coll Cardiol 2010;56:134-43.
6. Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole Clopidogrel Aspirin) study. J Am Coll Cardiol 2008;51:256-60.
7. Sibbing D, Morath T, Stegherr J, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb Haemost 2009;101: 714-9.